Skip to main content
Senior notes offering could pull in $3B for Thermo Fisher Scientific

An offering of floating rate senior notes due 2019, 1.4% senior notes due 2026, 1.95% senior notes due 2029 and 2.875% senior notes due 2037 has been priced by Thermo Fisher Scientific in hopes of obtaining approximately $3 billion. The company intends to use the net proceeds for partial funding of its $7.2 billion acquisition of Patheon, a pharmaceutical contract development and manufacturing firm.

Full Story: